SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-046497
Filing Date
2021-07-13
Accepted
2021-07-13 16:25:15
Documents
2
Period of Report
2021-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4050
2 POA DOCUMENT poa.txt EX-24.4_998875 4325
  Complete submission text file 0001209191-21-046497.txt   9788
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 W. HIGHLAND DR. #303 SEATTLE WA 98119
Business Address 484-680-8138
Poole Robert Michael (Reporting) CIK: 0001871782 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 211088125